Skip to content


Nipent (pentostatin) is a small molecule pharmaceutical. Pentostatin was first approved as Nipent on 1991-10-11. It is used to treat hairy cell leukemia in the USA. The pharmaceutical is active against adenosine deaminase. In addition, it is known to target adenosine deaminase.
Trade Name Nipent
Common Name Pentostatin
Indication hairy cell leukemia
Drug Class Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)
Get full access now